Citeline

Citeline (Pink Sheet / Citeline Insights) — Editorially-curated EU biosimilar regulatory event stream within the Pink Sheet European Performance Tracker: per-product filings, CHMP/EMA opinions and commission decisions, cross-referenced against the wider Pink Sheet regulatory-tracking corpus (product reviews, agency leadership, pathways and standards, drug safety, IP and litigation, HTA and payer coverage) spanning US, EU, Asia, LatAm and MEA agencies. Established mid-large regulatory-intelligence publisher: ~750 employees, information services, New York-registered, six branded subscription ti…

Citeline offers (Regulatory, Alternative, Reference) — Multi-decade archive across six tracked titles, with the EU biosimilar tracker alone covering every EU filing, opinion and approval decision; the wider Pink Sheet estate tracks thousands of pipeline products and thousands of regulatory decisions annually across all major agencies.

EU biosimilar entry-timing forecasts and erosion modelling; regulatory-timeline benchmarking by pathway and agency; agency-divergence alpha studies (EMA opinion to approval lag as a revenue-timing signal); HTA/payer-access prediction; fine-tuning biomedical LLMs on curated regulator-decision narratives

The data is with 40 years of history.

Coverage spans Other, US, Europe, Japan; Pharmaceuticals, Publishing; regulatory, alternative, reference; equities.